Creative Planning Amphastar Pharmaceuticals, Inc. Transaction History

Creative Planning

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 25, 2018	SELL	$15.39 - $19.38 $1.25 Million - $1.57 Million	-80,948 Closed	0 $0
Q1 2018 Apr 18, 2018	SELL	$17.23 - $20.35 $206,760 - $244,200	-12,000 Reduced 12.91%	80,948 $1.52 Million
Q4 2017 Jan 17, 2018	SELL	$17.76 - $19.75 $17,760 - $19,750	-1,000 Reduced 1.06%	92,948 $1.79 Million
Q3 2017 Oct 17, 2017	BUY	$14.73 - $17.99 $1.38 Million - $1.69 Million	93,948	93,948 $1.68 Million

287

35.1M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.14B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.